Viral Arthritis Vaccine Market Report 2026
Download Free Sample Buy Now
Viral Arthritis Vaccine Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Viral Arthritis Vaccine Market Report 2026

By Type (Viral Arthritis Vaccine, Live, Viral Arthritis Vaccine, Inactivated), By Virus Targeted (Chikungunya Virus, Rubella Virus, Parvovirus, Other Viral Arthritis-Causing Viruses), By Application (Farms, Individual), By End-User (Hospitals And Clinics, Vaccination Centers, Homecare, Government Programs) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Viral Arthritis Vaccine Market Overview

• Viral Arthritis Vaccine market size has reached to $6.66 billion in 2025

• Expected to grow to $11.09 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%

• Growth Driver: Rising Mosquito-Borne Viral Infections Driving Growth Of The Market Due To Increasing Cases Of Chikungunya And Related Viruses And Expanding Vaccination Efforts

• Market Trend: Advancement Of Live-Attenuated And Next-Generation Chikungunya Vaccines Strengthening Viral Arthritis Prevention

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Viral Arthritis Vaccine Market?

A viral arthritis vaccine refers to a preventive immunization designed to stimulate the immune system to produce protective antibodies and cellular immunity against viruses that can cause arthritis, such as Chikungunya virus, Ross River virus, and other arthritogenic viruses, thereby reducing the risk, severity, and long-term complications of virus-induced joint inflammation. It aims to prevent acute febrile illness and chronic inflammatory arthritis by blocking viral infection, limiting viral replication, and minimizing immune-mediated joint damage in exposed or high-risk populations.

The main types of viral arthritis vaccine include viral arthritis vaccine, live, and viral arthritis vaccine, inactivated. Viral arthritis vaccine, live, refers to vaccines that use a weakened form of the virus to stimulate immunity against viral arthritis. These vaccines target viruses such as chikungunya virus, rubella virus, parvovirus, and other viral arthritis-causing viruses. They are applied across farms and individual use, and are administered to end users including hospitals and clinics, vaccination centers, homecare, and government programs.

Viral Arthritis Vaccine Market Report bar graph

What Is The Viral Arthritis Vaccine Market Size and Share 2026?

The viral arthritis vaccine market size has grown rapidly in recent years. It will grow from $6.66 billion in 2025 to $7.36 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to chikungunya outbreak history, vaccine platform advances, global immunization programs, zoonotic virus research, public health preparedness efforts.

What Is The Viral Arthritis Vaccine Market Growth Forecast?

The viral arthritis vaccine market size is expected to see rapid growth in the next few years. It will grow to $11.09 billion in 2030 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to next generation vaccine platforms, emerging arbovirus threats, accelerated clinical trials, global travel related exposure, preventive immunization expansion. Major trends in the forecast period include mrna based viral arthritis vaccines, recombinant vector vaccine platforms, multivalent arthritogenic virus vaccines, rapid response vaccine design, adjuvanted immunogenic formulations.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Viral Arthritis Vaccine Market Segmentation

1) By Type: Viral Arthritis Vaccine, Live; Viral Arthritis Vaccine, Inactivated

2) By Virus Targeted: Chikungunya Virus; Rubella Virus; Parvovirus; Other Viral Arthritis-Causing Viruses

3) By Application: Farms; Individual

4) By End-User: Hospitals And Clinics; Vaccination Centers; Homecare; Government Programs

Subsegments:

1) By Viral Arthritis Vaccine, Live: Single Dose; Combination Dose; Recombinant Live Vaccine

2) By Viral Arthritis Vaccine, Inactivated: Whole Virus Inactivated Vaccine; Split Virus Inactivated Vaccine; Adjuvanted Inactivated Vaccine

What Is The Driver Of The Viral Arthritis Vaccine Market?

A rising incidence of mosquito-borne viral infections is expected to propel the growth of the viral arthritis vaccine market going forward. Mosquito-borne viral infections refer to diseases transmitted to humans through the bite of infected mosquitoes, including chikungunya, Zika, and dengue viruses, which can cause symptoms such as fever, joint pain, rash, and, in some cases, long-term complications like viral arthritis. Mosquito-borne viral infections are increasing due to climate change creating warmer temperatures and altered rainfall patterns that expand mosquito habitats and breeding seasons. A viral arthritis vaccine helps reduce mosquito-borne viral infections by preventing infection and disease progression from viruses that cause joint inflammation, thereby lowering transmission risk and disease burden in affected populations. For instance, in 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, over 7.6 million cases were reported globally by April, tripling the number recorded during the same period in 2023, with transmission continuing to spread across more than 90 countries. Therefore, the rising incidence of mosquito-borne viral infections is driving growth of the viral arthritis vaccine industry.

Key Players In The Global Viral Arthritis Vaccine Market

Major companies operating in the viral arthritis vaccine market are Bavarian Nordic A/S, Serum Institute of India Private Limited, Valneva SE, Bharat Biotech International Limited, Panacea Biotec Ltd., The Biologicals and Vaccines Institute of Southern Africa (Pty) Ltd.

Global Viral Arthritis Vaccine Market Trends and Insights

Major companies operating in the viral arthritis vaccine market are focusing on advancing innovative vaccine candidates, such as live-attenuated and next-generation chikungunya vaccines, to address the growing need for effective prevention of viral-induced joint pain and long-term arthritic complications, particularly in vulnerable populations. Live-attenuated and next-generation chikungunya vaccines refer to advanced vaccine formulations designed to prevent chikungunya virus infection by eliciting strong and long-lasting immune responses, where live-attenuated vaccines use weakened forms of the virus to closely mimic natural infection and provide durable protection, and next-generation vaccines employ modern platforms such as viral vectors, recombinant proteins, or novel attenuation technologies to enhance safety, immunogenicity, and broader population applicability. For instance, in June 2025, Bavarian Nordic A/S, a Denmark-based biotechnology company, initiated a Phase 3 clinical study of its chikungunya vaccine in children, aiming to expand protection to pediatric populations in endemic regions, where early-life exposure can lead to significant disease burden. The progression to late-stage clinical evaluation reflects growing confidence in the vaccine’s safety and immunogenicity profile and underscores efforts to broaden age indications, strengthen population-level immunity, and reduce the long-term impact of chikungunya-associated viral arthritis globally.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Viral Arthritis Vaccine Market?

In December 2024, Valneva SE, a France-based biotech company, partnered with the Serum Institute of India for its single-shot chikungunya vaccine under an exclusive licensing agreement. With this collaboration, the partners aimed to expand access to the vaccine across Asia and support broader supply to low- and middle-income countries, leveraging local manufacturing and regulatory capabilities. The Serum Institute of India is an India-based company that specializes in producing and distributing affordable vaccines at large scale to public health markets worldwide.

Regional Insights

North America was the largest region in the viral arthritis vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Viral Arthritis Vaccine Market?

The viral arthritis vaccine market consists of sales of live-attenuated viral vaccines, inactivated viral vaccines, virus-like particle-based vaccines, recombinant subunit vaccines, messenger ribonucleic acid-based vaccines, and viral vector-based vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Viral Arthritis Vaccine Market Report 2026?

The viral arthritis vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the viral arthritis vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Viral Arthritis Vaccine Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $7.36 billion
Revenue Forecast In 2035 $11.09 billion
Growth Rate CAGR of 10.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Virus Targeted, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Bavarian Nordic A/S, Serum Institute of India Private Limited, Valneva SE, Bharat Biotech International Limited, Panacea Biotec Ltd., The Biologicals and Vaccines Institute of Southern Africa (Pty) Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Viral Arthritis Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Viral Arthritis Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Viral Arthritis Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Viral Arthritis Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Mrna Based Viral Arthritis Vaccines

4.2.2 Recombinant Vector Vaccine Platforms

4.2.3 Multivalent Arthritogenic Virus Vaccines

4.2.4 Rapid Response Vaccine Design

4.2.5 Adjuvanted Immunogenic Formulations

5. Viral Arthritis Vaccine Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Vaccination Centers

5.3 Government Immunization Programs

5.4 Public Health Agencies

5.5 Travel Health Centers

6. Viral Arthritis Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Viral Arthritis Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Viral Arthritis Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Viral Arthritis Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Viral Arthritis Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Viral Arthritis Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Viral Arthritis Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Viral Arthritis Vaccine Market Segmentation

9.1. Global Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Arthritis Vaccine, Live, Viral Arthritis Vaccine, Inactivated

9.2. Global Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chikungunya Virus, Rubella Virus, Parvovirus, Other Viral Arthritis-Causing Viruses

9.3. Global Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Farms, Individual

9.4. Global Viral Arthritis Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Vaccination Centers, Homecare, Government Programs

9.5. Global Viral Arthritis Vaccine Market, Sub-Segmentation Of Viral Arthritis Vaccine, Live, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Single Dose, Combination Dose, Recombinant Live Vaccine

9.6. Global Viral Arthritis Vaccine Market, Sub-Segmentation Of Viral Arthritis Vaccine, Inactivated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Whole Virus Inactivated Vaccine, Split Virus Inactivated Vaccine, Adjuvanted Inactivated Vaccine

10. Viral Arthritis Vaccine Market Regional And Country Analysis

10.1. Global Viral Arthritis Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Viral Arthritis Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Viral Arthritis Vaccine Market

11.1. Asia-Pacific Viral Arthritis Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Viral Arthritis Vaccine Market

12.1. China Viral Arthritis Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Viral Arthritis Vaccine Market

13.1. India Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Viral Arthritis Vaccine Market

14.1. Japan Viral Arthritis Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Viral Arthritis Vaccine Market

15.1. Australia Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Viral Arthritis Vaccine Market

16.1. Indonesia Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Viral Arthritis Vaccine Market

17.1. South Korea Viral Arthritis Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Viral Arthritis Vaccine Market

18.1. Taiwan Viral Arthritis Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Viral Arthritis Vaccine Market

19.1. South East Asia Viral Arthritis Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Viral Arthritis Vaccine Market

20.1. Western Europe Viral Arthritis Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Viral Arthritis Vaccine Market

21.1. UK Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Viral Arthritis Vaccine Market

22.1. Germany Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Viral Arthritis Vaccine Market

23.1. France Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Viral Arthritis Vaccine Market

24.1. Italy Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Viral Arthritis Vaccine Market

25.1. Spain Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Viral Arthritis Vaccine Market

26.1. Eastern Europe Viral Arthritis Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Viral Arthritis Vaccine Market

27.1. Russia Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Viral Arthritis Vaccine Market

28.1. North America Viral Arthritis Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Viral Arthritis Vaccine Market

29.1. USA Viral Arthritis Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Viral Arthritis Vaccine Market

30.1. Canada Viral Arthritis Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Viral Arthritis Vaccine Market

31.1. South America Viral Arthritis Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Viral Arthritis Vaccine Market

32.1. Brazil Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Viral Arthritis Vaccine Market

33.1. Middle East Viral Arthritis Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Viral Arthritis Vaccine Market

34.1. Africa Viral Arthritis Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Viral Arthritis Vaccine Market, Segmentation By Type, Segmentation By Virus Targeted, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Viral Arthritis Vaccine Market Regulatory and Investment Landscape

36. Viral Arthritis Vaccine Market Competitive Landscape And Company Profiles

36.1. Viral Arthritis Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Viral Arthritis Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Viral Arthritis Vaccine Market Company Profiles

36.3.1. Bavarian Nordic A/S Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Serum Institute of India Private Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Valneva SE Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bharat Biotech International Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Panacea Biotec Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Viral Arthritis Vaccine Market Other Major And Innovative Companies

The Biologicals and Vaccines Institute of Southern Africa (Pty) Ltd.

38. Global Viral Arthritis Vaccine Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Viral Arthritis Vaccine Market

41. Viral Arthritis Vaccine Market High Potential Countries, Segments and Strategies

41.1 Viral Arthritis Vaccine Market In 2030 - Countries Offering Most New Opportunities

41.2 Viral Arthritis Vaccine Market In 2030 - Segments Offering Most New Opportunities

41.3 Viral Arthritis Vaccine Market In 2030 - Growth Strategies

41.3.1 Market Trend Based Strategies

41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic And Forecast Inflation Rates

42.4. Research Inquiries

42.5. The Business Research Company

42.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Viral Arthritis Vaccine Market, Overview Of Key Products - Product Examples
  • Table 2: Global Viral Arthritis Vaccine Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Viral Arthritis Vaccine Market, Supply Chain Analysis
  • Table 4: Global Viral Arthritis Vaccine Market, Major Raw Material Providers
  • Table 5: Global Viral Arthritis Vaccine Market, Major Resource Providers
  • Table 6: Global Viral Arthritis Vaccine Market, Major Manufacturers (Suppliers)
  • Table 7: Global Viral Arthritis Vaccine Market, Major Distributors And Channel Partners
  • Table 8: Global Viral Arthritis Vaccine Market, Key Technologies & Future Trends
  • Table 9: Global Viral Arthritis Vaccine Market, Major Trends
  • Table 10: Global Viral Arthritis Vaccine Market, Major End Users
  • Table 11: Global Viral Arthritis Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Viral Arthritis Vaccine Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Viral Arthritis Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Viral Arthritis Vaccine Market - TAM, US$ Billion, 2025
  • Table 15: Global Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Viral Arthritis Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Viral Arthritis Vaccine Market, Sub-Segmentation Of Viral Arthritis Vaccine, Live, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Viral Arthritis Vaccine Market, Sub-Segmentation Of Viral Arthritis Vaccine, Inactivated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Viral Arthritis Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Viral Arthritis Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Viral Arthritis Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Viral Arthritis Vaccine Market - Company Scoring Matrix
  • Table 97: Upcoming Startups
  • Table 98: Bavarian Nordic A/S Financial Performance
  • Table 99: Serum Institute of India Private Limited Financial Performance
  • Table 100: Valneva SE Financial Performance
  • Table 101: Bharat Biotech International Limited Financial Performance
  • Table 102: Panacea Biotec Ltd. Financial Performance
  • Table 103: Global Viral Arthritis Vaccine Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Viral Arthritis Vaccine Market, Competitive Dashboard
  • Table 105: Global Viral Arthritis Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Viral Arthritis Vaccine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 107: Global, Viral Arthritis Vaccine Market Size Gain ($ Billion), Segmentation By Virus Targeted, 2025 – 2030
  • Table 108: Global, Viral Arthritis Vaccine Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

    Figure 1: Global Viral Arthritis Vaccine Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Viral Arthritis Vaccine Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Viral Arthritis Vaccine Market, Supply Chain Analysis
  • Figure 4: Global Viral Arthritis Vaccine Market, Major Raw Material Providers
  • Figure 5: Global Viral Arthritis Vaccine Market, Major Resource Providers
  • Figure 6: Global Viral Arthritis Vaccine Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Viral Arthritis Vaccine Market, Major Distributors And Channel Partners
  • Figure 8: Global Viral Arthritis Vaccine Market, Key Technologies & Future Trends
  • Figure 9: Global Viral Arthritis Vaccine Market, Major Trends
  • Figure 10: Global Viral Arthritis Vaccine Market, Major End Users
  • Figure 11: Global Viral Arthritis Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Viral Arthritis Vaccine Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Viral Arthritis Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Viral Arthritis Vaccine Market - TAM, US$ Billion, 2025
  • Figure 15: Global Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Viral Arthritis Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Viral Arthritis Vaccine Market, Sub-Segmentation Of Viral Arthritis Vaccine, Live, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Viral Arthritis Vaccine Market, Sub-Segmentation Of Viral Arthritis Vaccine, Inactivated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Viral Arthritis Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Viral Arthritis Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Viral Arthritis Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Viral Arthritis Vaccine Market, Segmentation By Virus Targeted, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Viral Arthritis Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Viral Arthritis Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Viral Arthritis Vaccine Market - Company Scoring Matrix
  • Figure 97: Upcoming Startups
  • Figure 98: Bavarian Nordic A/S Financial Performance
  • Figure 99: Serum Institute of India Private Limited Financial Performance
  • Figure 100: Valneva SE Financial Performance
  • Figure 101: Bharat Biotech International Limited Financial Performance
  • Figure 102: Panacea Biotec Ltd. Financial Performance
  • Figure 103: Global Viral Arthritis Vaccine Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Viral Arthritis Vaccine Market, Competitive Dashboard
  • Figure 105: Global Viral Arthritis Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Viral Arthritis Vaccine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 107: Global, Viral Arthritis Vaccine Market Size Gain ($ Billion), Segmentation By Virus Targeted, 2025 – 2030
  • Figure 108: Global, Viral Arthritis Vaccine Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

Behavioral Rehabilitation Market Report 2026 - Global Outlook – By Treatment Method (Counseling, Medication, Support Services, Other Treatment Methods), By Application (Anxiety Disorders, Mood Disorders, Substance Abuse ...

Metal Forging Market Report 2026 - Global Outlook – By Type (Closed-Die Forging, Open-Die Forging, Ring Rolling), By Raw Material (Carbon Steel, Alloy Steel, Aluminum, Stainless Steel, Titanium, Other Raw Materials), By ...

Automatic Effluent Samplers Market Report 2026 - Global Outlook – By Product Type (Portable Samplers, Stationary Samplers), By Distribution Channel (Direct Sales, Distributors), By Application (Industrial Wastewater, Mun...

UV Disinfection Equipment Market Report 2026 - Global Outlook – By Component (UV Lamp, Controller Unit, Quartz Sleeve, Reactor Chamber, Other Components ), By Power Rating (Low, Medium, High ), By Application (Water Trea...

Genu Recurvatum Market Report 2026 - Global Outlook – By Type (External Rotatory Deformity (ERD), Internal Rotatory Deformity (IRD), Non-Rotatory Deformity (NRD)), By Diagnosis (Magnetic Resonance Imaging (MRI), X-Rays, ...

Entertainment Buildings Market Report 2026 - Global Outlook – By Type (Residential, Non-residential), By Construction Type (New Construction, Renovation), By Application (Owned, Rental), By End User (Private, Public) – M...

Frequently Asked Questions

The Viral Arthritis Vaccine market was valued at $6.66 billion in 2025, increased to $7.36 billion in 2026, and is projected to reach $11.09 billion by 2030.

The global Viral Arthritis Vaccine market is expected to grow at a CAGR of 10.8% from 2026 to 2035 to reach $11.09 billion by 2035.

Some Key Players in the Viral Arthritis Vaccine market Include, Bavarian Nordic A/S, Serum Institute of India Private Limited, Valneva SE, Bharat Biotech International Limited, Panacea Biotec Ltd., The Biologicals and Vaccines Institute of Southern Africa (Pty) Ltd. .

Major trend in this market includes: Advancement Of Live-Attenuated And Next-Generation Chikungunya Vaccines Strengthening Viral Arthritis Prevention. For further insights on this market. request a sample here

North America was the largest region in the viral arthritis vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral arthritis vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us